Polycystic Ovary Syndrome

Dr. Rehana Rehman has 20 years of teaching experience in the field of physiology. She is a well-recognized authority in the field of reproductive physiology and is working to identify treatable causes of infertility in collaboration with the Australian Concept Infertility Medical Centre. She has more than 200 publications in high impact national & international journal and 60 abstract presentations (oral and poster) in local and international conferences. Her book "Five Minutes to Wellness” is based on holistic review of all dimensions of wellness of medical students. She is a member of the Society for Endocrinology and the European Society of Human Reproduction & Endocrinology. Dr. Aisha Sheikh is a Consultant Endocrinologist. She is actively involved in medical education and research and she has published several research papers and book chapters. Dr. Sheikh is currently the Joint Secretary of Pakistan Endocrine Society. She has keen interest in antenatal Diabetes & Endocrinology and has played a key role in development of Gestational Diabetes Mellitus recommendations and action plans from the platform of the South Asian Federation of Endocrine Societies (SAFES). She has written book chapters, published her research findings, and presented her research at international meetings. She is a member of the Pakistan Endocrine Society and American Association of Clinical Endocrinologists.

SECTION I Overview of Polycystic Syndrome
1 Introduction to Polycystic Ovary Syndrome
2 Polycystic Ovary Syndrome Phenotypes
3 Polycystic Ovary Syndrome Adolescents
SECTION II Pathogenesis and Clinical Presentation
4 Pathophysiology of Polycystic Ovary Syndrome
5 Interplay of Adipocytokines With Polycystic Ovary Syndrome
6 Crosstalk between Oxidative Stress and Chronic Inflammation in Pathogenesis of Polycystic Ovary Syndrome
7 Polycystic Ovary Syndrome and Subfertility: Ovulation Dysregulation and Fertility Problems (Clinical Features and Pathophysiology)
8 Clinical Features and Presentation of Polycystic Ovary Syndrome 56
9 Diagnostic Criteria for Polycystic Ovary Syndrome
10 Polycystic Ovary Syndrome and Metabolic Syndrome: Risks in Later Life
11 Polycystic Ovary Syndrome and Mental Health
12 Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease
13 Male Polycystic Ovary Syndrome Equivalent
SECTION III Management of Polycystic Ovary Syndrome and Associated Comorbidities
14 Pharmacologic Management of PCOS: Menstrual Irregularities
15 Pharmacologic Management for Polycystic Ovary Syndrome: Hirsutism and Acne
16 Pharmacologic Management for Polycystic Ovary Syndrome: Weight Loss
17 Role of Insulin Sensitizers in the Management of Polycystic Ovary Syndrome
18 Cardiovascular Risk Reduction in Polycystic Ovary Syndrome
19 Management of Subfertility in Polycystic Ovary Syndrome
20 Management of Associated Risks of Pregnancy in Polycystic Ovary Syndrome
21 Importance of Lifestyle Modifications
22 Role of Complementary and Alternative Medicine in Polycystic Ovary Syndrome 23 Evidence-Based Recommendations for Clinical Practice (Future Directions: Research and Practice)
SECTION IV Global Approach to Polycystic Ovary Syndrome
24 Polycystic Ovary Syndrome in South Asians
25 Situation Analysis of Polycystic Ovary Syndrome in Central and East Asia
26 Situational Analysis of Polycystic Ovary Syndrome in Southeast Asia
27 Situation Analysis of Polycystic Ovary Syndrome in Western Asia
28 Situation Analysis, Cultural Beliefs, Lifestyle,and the Psychological Impact of Polycystic Ovary Syndrome in Europe
29 Global Approach to Polycystic Ovary Syndrome in Africa
30 Polycystic Ovary Syndrome in North America